| Common genetic variation and the control of HIV-1 in humans J Fellay, D Ge, KV Shianna, S Colombo, B Ledergerber, ET Cirulli, ... PLoS genetics 5 (12), e1000791, 2009 | 468 | 2009 |
| Long-term antiretroviral treatment initiated at primary HIV-1 infection affects the size, composition, and decay kinetics of the reservoir of HIV-1-infected CD4 T cells MJ Buzon, E Martin-Gayo, F Pereyra, Z Ouyang, H Sun, JZ Li, M Piovoso, ... Journal of virology 88 (17), 10056-10065, 2014 | 309 | 2014 |
| A dendritic cell–based vaccine elicits T cell responses associated with control of HIV-1 replication F García, N Climent, AC Guardo, C Gil, A León, B Autran, JD Lifson, ... Science translational medicine 5 (166), 166ra2-166ra2, 2013 | 239 | 2013 |
| Comparative transcriptomics of extreme phenotypes of human HIV-1 infection and SIV infection in sooty mangabey and rhesus macaque M Rotger, J Dalmau, A Rauch, P McLaren, SE Bosinger, R Martinez, ... The Journal of clinical investigation 121 (6), 2391-2400, 2011 | 221 | 2011 |
| Polymorphisms of large effect explain the majority of the host genetic contribution to variation of HIV-1 virus load PJ McLaren, C Coulonges, I Bartha, TL Lenz, AJ Deutsch, A Bashirova, ... Proceedings of the National Academy of Sciences 112 (47), 14658-14663, 2015 | 178 | 2015 |
| A therapeutic dendritic cell-based vaccine for HIV-1 infection F García, N Climent, L Assoumou, C Gil, N González, J Alcamí, A León, ... Journal of Infectious Diseases 203 (4), 473-478, 2011 | 143 | 2011 |
| A genome-to-genome analysis of associations between human genetic variation, HIV-1 sequence diversity, and viral control I Bartha, JM Carlson, CJ Brumme, PJ McLaren, ZL Brumme, M John, ... elife 2, e01123, 2013 | 138 | 2013 |
| Association study of common genetic variants and HIV-1 acquisition in 6,300 infected cases and 7,200 controls PJ McLaren, C Coulonges, S Ripke, L Van Den Berg, S Buchbinder, ... PLoS pathogens 9 (7), e1003515, 2013 | 137 | 2013 |
| HIV-1 immune activation induces Siglec-1 expression and enhances viral trans-infection in blood and tissue myeloid cells M Pino, I Erkizia, S Benet, E Erikson, MT Fernández-Figueras, D Guerrero, ... Retrovirology 12, 1-15, 2015 | 99 | 2015 |
| Assessment of the feasibility and safety of durvalumab for treatment of solid tumors in patients with HIV-1 infection: the phase 2 DURVAST study M Gonzalez-Cao, T Morán, J Dalmau, J Garcia-Corbacho, JWP Bracht, ... JAMA oncology 6 (7), 1063-1067, 2020 | 81 | 2020 |
| Deep molecular characterization of HIV-1 dynamics under suppressive HAART MJ Buzon, FM Codoner, SDW Frost, C Pou, MC Puertas, M Massanella, ... PLoS pathogens 7 (10), e1002314, 2011 | 74 | 2011 |
| A minor population of macrophage-tropic HIV-1 variants is identified in recrudescing viremia following analytic treatment interruption VM Andrade, C Mavian, D Babic, T Cordeiro, M Sharkey, L Barrios, ... Proceedings of the National Academy of Sciences 117 (18), 9981-9990, 2020 | 56 | 2020 |
| Contribution of immunological and virological factors to extremely severe primary HIV type 1 infection J Dalmau, MC Puertas, M Azuara, A Marino, N Frahm, B Mothe, NI Useros, ... Clinical infectious diseases 48 (2), 229-238, 2009 | 55 | 2009 |
| Post COVID-19 condition in children and adolescents: an emerging problem J Izquierdo-Pujol, S Moron-Lopez, J Dalmau, A Gonzalez-Aumatell, ... Frontiers in pediatrics 10, 894204, 2022 | 54 | 2022 |
| A genome-wide association study of resistance to HIV infection in highly exposed uninfected individuals with hemophilia A J Lane, PJ McLaren, L Dorrell, KV Shianna, A Stemke, K Pelak, S Moore, ... Human molecular genetics 22 (9), 1903-1910, 2013 | 48 | 2013 |
| The HIV-1 integrase genotype strongly predicts raltegravir susceptibility but not viral fitness of primary virus isolates MJ Buzón, J Dalmau, MC Puertas, J Puig, B Clotet, J Martinez-Picado Aids 24 (1), 17-25, 2010 | 45 | 2010 |
| Identification of Siglec-1 null individuals infected with HIV-1 J Martinez-Picado, PJ McLaren, I Erkizia, MP Martin, S Benet, M Rotger, ... Nature communications 7 (1), 12412, 2016 | 35 | 2016 |
| Enhancement of Antiviral CD8+ T-Cell Responses and Complete Remission of Metastatic Melanoma in an HIV-1-Infected Subject Treated with Pembrolizumab O Blanch-Lombarte, C Gálvez, B Revollo, E Jiménez-Moyano, JM Llibre, ... Journal of clinical medicine 8 (12), 2089, 2019 | 27 | 2019 |
| Does rapid HIV disease progression prior to combination antiretroviral therapy hinder optimal CD4+ T-cell recovery once HIV-1 suppression is achieved? I Jarrin, N Pantazis, J Dalmau, AN Phillips, A Olson, C Mussini, ... Aids 29 (17), 2323-2333, 2015 | 27 | 2015 |
| In–depth characterization of viral isolates from plasma and cells compared with plasma circulating quasispecies in early HIV-1 infection J Dalmau, FM Codoner, I Erkizia, M Pino, C Pou, R Paredes, B Clotet, ... PloS one 7 (2), e32714, 2012 | 25 | 2012 |
Javier Martinez-PicadoICREA, irsiCaixa, UVic-UCC, CiberInfecEmail confirmado em irsicaixa.es
